SEC Insider Transactions from Janku Filip.

Last updated: 2026-03-14 11:52 UTC | Total transactions: 8

Filip Janku, Chief Medical Officer of Monte Rosa Therapeutics ($GLUE), sold shares on the open market twice in the last year, totaling $227,000. His most recent sale occurred on February 23, 2026. These sales rank 8,151st among 11,678 individual insiders, where the average is $8.6 million across about six transactions. Janku made no open market purchases during this period.

Set Up your own filters →
Transaction Date Company Ticker Insider Name Title Transaction Type Security Shares Price Shares Owned Following Total Shares Outstanding % of Owned % of Outstanding
Feb. 23, 2026 Monte Rosa Therapeutics, Inc. $GLUE Janku Filip Chief Medical Officer S Common Stock 9189 $19.50 65,837.0000 82,942,723 12.25% 0.01%
Jan. 2, 2026 Monte Rosa Therapeutics, Inc. $GLUE Janku Filip Chief Medical Officer A Common Stock 31000 $0.00 78,181.0000 82,942,723 65.70% 0.04%
Jan. 5, 2026 Monte Rosa Therapeutics, Inc. $GLUE Janku Filip Chief Medical Officer S Common Stock 3155 $15.17 75,026.0000 82,942,723 4.04% 0.00%
Jan. 2, 2026 Monte Rosa Therapeutics, Inc. $GLUE Janku Filip Chief Medical Officer A Stock Option (Right to Buy) 139000 $0.00 139,000.0000 82,942,723 9999.99% 0.17%
Jan. 2, 2025 Monte Rosa Therapeutics, Inc. $GLUE Janku Filip Chief Medical Officer A Common Stock 36000 $0.00 45,189.0000 73,910,026 391.77% 0.05%
Jan. 2, 2025 Monte Rosa Therapeutics, Inc. $GLUE Janku Filip Chief Medical Officer A Stock Option (Right to Buy) 161000 $0.00 161,000.0000 73,910,026 9999.99% 0.22%
Sept. 13, 2024 Monte Rosa Therapeutics, Inc. $GLUE Janku Filip Chief Medical Officer A Stock Option (Right to Buy) 30000 $0.00 30,000.0000 51,396,961 9999.99% 0.06%
Jan. 2, 2024 Monte Rosa Therapeutics, Inc. $GLUE Janku Filip Chief Medical Officer A Stock Option (Right to Buy) 121000 $0.00 121,000.0000 51,396,961 9999.99% 0.24%